Shaker, Olfat GAyeldeen, GAbdelhamid, A.M2020-06-192020-06-195/18/2020Bhandari, A., Woodhouse, M., Gupta, S. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: A SEER-based analysis with comparison to other young-onset cancers (Open Access) (2017) Journal of Investigative Medicine, 65 (2), pp. 311-315. Cited 55 times. http://jim.bmj.com/content/about-us doi: 10.1136/jim-2016-000229 View at Publisher 2 Christensen, L.L., Tobiasen, H., Holm, A., Schepeler, T., Ostenfeld, M.S., Thorsen, K., Rasmussen, M.H., (...), Andersen, C.L. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer (2013) International Journal of Cancer, 133 (1), pp. 67-78. Cited 64 times. doi: 10.1002/ijc.28010 View at Publisher 3 Di, W., Weinan, X., Xin, L., Zhiwei, Y., Xinyue, G., Jinxue, T., Mingqi, L. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7 (Open Access) (2019) Cell Death and Disease, 10 (7), art. no. 514. Cited 19 times. http://www.nature.com/cddis/marketing/index.html doi: 10.1038/s41419-019-1707-x View at Publisher 4 Eberle, F.C., Rodriguez-Canales, J., Wei, L., Hanson, J.C., Killian, J.K., Hong-Wei, S., Adams, L.G., (...), Jaffe, E.S. Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma (Open Access) (2011) Haematologica, 96 (4), pp. 558-566. Cited 88 times. http://www.haematologica.org/cgi/reprint/96/4/558 doi: 10.3324/haematol.2010.033167 View at Publisher 5 Edge, S.B., Compton, C.C. The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM (Open Access) (2010) Annals of Surgical Oncology, 17 (6), pp. 1471-1474. Cited 4456 times. doi: 10.1245/s10434-010-0985-4 View at Publisher 6 Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., (...), Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 (2015) International Journal of Cancer, 136 (5), pp. E359-E386. Cited 15257 times. http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215 doi: 10.1002/ijc.29210 View at Publisher 7 Guan, M., Xu, C., Zhang, F., Ye, C. Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features (2009) International Journal of Cancer, 124 (1), pp. 88-94. Cited 46 times. http://www3.interscience.wiley.com/cgi-bin/fulltext/121422655/PDFSTART doi: 10.1002/ijc.23890 View at Publisher 8 Hafner, C., Schmitz, G., Meyer, S., Bataille, F., Hau, P., Langmann, T., Dietmaier, W., (...), Vogt, T. Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and Cancers (Open Access) (2004) Clinical Chemistry, 50 (3), pp. 490-499. Cited 248 times. doi: 10.1373/clinchem.2003.026849 View at Publisher 9 He, Z., Xu, H., Meng, Y., Kuang, Y. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer (2017) Biomedicine and Pharmacotherapy, 88, pp. 902-910. Cited 21 times. www.elsevier.com/locate/biomedpharm doi: 10.1016/j.biopha.2017.01.117 View at Publisher 10 Ibrahim, A.S., Khaled, H.M., Mikhail, N.N., Baraka, H., Kamel, H. Cancer incidence in Egypt: Results of the national population-based cancer registry program (Open Access) (2014) Journal of Cancer Epidemiology, 2014, art. no. 437971. Cited 212 times. http://www.hindawi.com/journals/jce/ doi: 10.1155/2014/437971 View at Publisher 11 Kim, Y.-J., Lee, J.H., Jin, S., Kim, J.H., Kim, S.H. Primate-specific miR-944 activates p53-dependent tumor suppression in human colorectal cancers (2019) Cancer Letters, 440-441, pp. 168-179. Cited 5 times. www.elsevier.com/locate/canlet doi: 10.1016/j.canlet.2018.10.029 View at Publisher 12 Krol, J., Loedige, I., Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay (2010) Nature Reviews Genetics, 11 (9), pp. 597-610. Cited 2709 times. doi: 10.1038/nrg2843 View at Publisher 13 Li, R., Sun, Y., Jiang, A., Wu, Y., Li, C., Jin, M., Yan, H., (...), Jin, H. Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells (Open Access) (2016) Molecular Medicine Reports, 13 (4), pp. 3190-3196. Cited 6 times. http://www.spandidos-publications.com/mmr/13/4/3190/download doi: 10.3892/mmr.2016.4904 View at Publisher 14 Li, S., Wu, Z., Ma, P., Xu, Y., Chen, Y., Wang, H., He, P., (...), Guan, M. Ligand-dependent EphA7 signaling inhibits prostate tumor growth & progression (Open Access) (2017) Cell Death and Disease, 8 (10), art. no. e3122. Cited 15 times. http://www.nature.com/cddis/marketing/index.html doi: 10.1038/cddis.2017.507 View at Publisher 15 Li, Y.-F., Hsiao, Y.-H., Lai, Y.-H., Chen, Y.-C., Chen, Y.-J., Chou, J.-L., Chan, M.W.Y., (...), Tai, C.-K. DNA methylation profiles and biomarkers of oral squamous cell carcinoma (Open Access) (2015) Epigenetics, 10 (3), pp. 229-236. Cited 26 times. http://www.tandfonline.com/doi/pdf/10.1080/15592294.2015.1006506 doi: 10.1080/15592294.2015.1006506 View at Publisher 16 Lisabeth, E.M., Falivelli, G., Pasquale, E.B. Eph receptor signaling and ephrins (Open Access) (2013) Cold Spring Harbor Perspectives in Biology, 5 (9). Cited 168 times. http://cshperspectives.cshlp.org/content/5/9/a009159.full.pdf+html doi: 10.1101/cshperspect.a009159 View at Publisher 17 Liu, M., Zhou, K., Cao, Y. MicroRNA-944 affects cell growth by targeting EPHA7 in non-small cell lung cancer (Open Access) (2016) International Journal of Molecular Sciences, 17 (10), art. no. 1493. Cited 20 times. http://www.mdpi.com/1422-0067/17/10/1493/pdf doi: 10.3390/ijms17101493 View at Publisher 18 oĹpez-nieva, P., Vaquero, C., Fernández-navarro, P., González-sánchez, L., Villa-morales, M., Santos, J., Esteller, M., (...), Fernández-piqueras, J. EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas (Open Access) (2012) Carcinogenesis, 33 (2), pp. 452-458. Cited 20 times. doi: 10.1093/carcin/bgr271 View at Publisher 19 Ma, J., Mannoor, K., Gao, L., Tan, A., Guarnera, M.A., Zhan, M., Shetty, A., (...), Jiang, F. Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing (Open Access) (2014) Molecular Oncology, 8 (7), pp. 1208-1219. Cited 58 times. http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/ doi: 10.1016/j.molonc.2014.03.019 View at Publisher 20 Nakamura, R., Kataoka, H., Sato, N., Kanamori, M., Ihara, M., Igarashi, H., Ravshanov, S., (...), Sugimura, H. EPHA2/EFNA1 expression in human gastric cancer (2005) Cancer Science, 96 (1), pp. 42-47. Cited 98 times. doi: 10.1111/j.1349-7006.2005.00007.x View at Publisher 21 Neudecker, V., Brodsky, K.S., Kreth, S., Ginde, A.A., Eltzschig, H.K. Emerging Roles for MicroRNAs in Perioperative Medicine (2016) Anesthesiology, 124 (2), pp. 489-506. Cited 29 times. http://journals.lww.com/anesthesiology/pages/default.aspx doi: 10.1097/ALN.0000000000000969 View at Publisher 22 Nordentoft, I., Birkenkamp-Demtroder, K., Agerbæk, M., Theodorescu, D., Ostenfeld, M.S., Hartmann, A., Borre, M., (...), Dyrskjøt, L. MiRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer (Open Access) (2012) BMC Medical Genomics, 5, art. no. 40. Cited 72 times. doi: 10.1186/1755-8794-5-40 View at Publisher 23 Schultz, N.A., Andersen, K.K., Roslind, A., Willenbrock, H., Wøjdemann, M., Johansen, J.S. Prognostic MicroRNAs in cancer tissue from patients operated for pancreatic cancer - Five MicroRNAs in a prognostic index (2012) World Journal of Surgery, 36 (11), pp. 2699-2707. Cited 60 times. doi: 10.1007/s00268-012-1705-y View at Publisher 24 Surawska, H., Ma, P.C., Salgia, R. The role of ephrins and Eph receptors in cancer (2004) Cytokine and Growth Factor Reviews, 15 (6), pp. 419-433. Cited 251 times. doi: 10.1016/j.cytogfr.2004.09.002 View at Publisher 25 Tait, S.W.G., Green, D.R. Mitochondria and cell death: Outer membrane permeabilization and beyond (2010) Nature Reviews Molecular Cell Biology, 11 (9), pp. 621-632. Cited 1450 times. doi: 10.1038/nrm2952 View at Publisher 26 Üçüncü, M., Serilmez, M., Sari, M., Bademler, S., Karabulut, S. The diagnostic significance of PDGF, EphA7, CCR5, and CCL5 levels in colorectal cancer (Open Access) (2019) Biomolecules, 9 (9), art. no. 464. Cited 3 times. https://www.mdpi.com/2218-273X/9/9/464/pdf doi: 10.3390/biom9090464 View at Publisher 27 Wang, J., Kataoka, H., Suzuki, M., Sato, N., Nakamura, R., Tao, H., Maruyama, K., (...), Sugimura, H. Downregulation of EphA7 by hypermethylation in colorectal cancer (Open Access) (2005) Oncogene, 24 (36), pp. 5637-5647. Cited 87 times. doi: 10.1038/sj.onc.1208720 View at Publisher 28 Wen, L., Li, Y., Jiang, Z., Zhang, Y., Yang, B., Han, F. MiR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer (2017) Oncology Reports, 37 (6), pp. 3415-3422. Cited 16 times. https://www.spandidos-publications.com/or/37/6/3415 doi: 10.3892/or.2017.5611 View at Publisher 29 Yörüker, E.E., Holdenrieder, S., Gezer, U. Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer (2016) Clinica Chimica Acta, 455, pp. 26-32. Cited 39 times. www.elsevier.com/locate/clinchim doi: 10.1016/j.cca.2016.01.01613813455https://doi.org/10.1080/13813455.2020.1762658https://t.ly/LXQQScopusMicroRNAs (miRNAs) have critical roles in colorectal cancer (CRC) tumorigenesis and development. It has been reported that Eph receptor A7 (EphA7) was a potential target of miR-944 which is transcriptionally activated in cancer. The aim of this study was to explore the expression profile of miR-944 and its target gene EPHA7 in the serum of Egyptian CRC patients. 150 CRC patients, 50 adenomatous polyps (AP) patients, and 100 healthy controls were included. Serum miR-944 was downregulated (0.304 ± 0.0512) while serum EPHA7 was upregulated (3.163 ± 0.610) in CRC and AP patients versus controls and discriminated aganst these groups by Receiver operating characteristic curve (ROC) analysis. miR-944 presented the highest diagnostic accuracy for CRC patients from control (AUC = 0.90). Moreover obvious prognostic power in distinguishing AP from CRC (AUC = 0.87). In conclusion, miR-944 and EPHA7 are potential genetic markers of CRC predisposition and novel potential non-invasive diagnostic biomarkers for CRC. © 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Groupen-USEPHA7-CRCmiR-944Articlehttps://doi.org/10.1080/13813455.2020.1762658